Contour Injection Composition for Fat Breakdown Without Skin Sagging

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Conventional lipolytic injections for fat removal suffer from side effects such as swelling, hematoma, pain, itchiness, burning sensation, and skin sagging, and fail to achieve satisfactory fat decomposition and elasticity improvement.

Innovation Solution

A contour injection composition comprising aminophylline, procaine, epinephrine, hyaluronidase, half saline, distilled water, choline alfoscerate, carbonated water, vitamin B1, and Asparagopsis taxiformis extract, formulated to enhance fat decomposition and elasticity while minimizing side effects.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional lipolytic injections containing phosphatidylcholine, deoxycholic acid, and hyaluronidase are used for fat removal, then fat decomposition effect is achieved, but side effects such as swelling, hematoma, pain, itchiness, burning sensation, and skin sagging occur

Engineering Contradiction:
Improvefat decomposition effectVSAvoidside effects (swelling, hematoma, pain, itchiness, burning sensation, skin sagging)
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent combines multiple ingredients (aminophylline, procaine, epinephrine, hyaluronidase, choline alfoscerate, carbonated water, vitamin B1, and Asparagopsis taxiformis extract) into a single injection composition that works synergistically to achieve fat decomposition while minimizing side effects through the combined actions of these components

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The injection composition uses a composite formulation with multiple active ingredients and excipients working together, where each component contributes specific functions (fat decomposition, pain relief, circulation improvement, elasticity enhancement) to achieve the desired effect while reducing adverse reactions

Inventive Principle:
Principle #40Composite materials

2Reliability

If high doses of hyaluronidase are used in lipolytic injections, then fat decomposition effect is enhanced, but skin sagging and wrinkles occur

Engineering Contradiction:
Improvefat decomposition effectVSAvoidskin sagging and wrinkles
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent optimizes the dosage parameters of hyaluronidase (500-700 IU units) and combines it with other ingredients that modulate its effects, changing the parameter range to achieve effective fat decomposition while preventing skin sagging and wrinkles through the balanced composition

Inventive Principle:
Principle #35Parameter changes

3Reliability

If conventional lipolytic injections are used alone for fat removal, then some fat decomposition is achieved, but satisfactory level of lipolytic effect cannot be obtained

Engineering Contradiction:
Improvelipolytic effect levelVSAvoidfat removal efficiency
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent merges multiple ingredients with complementary mechanisms of action (aminophylline for fat metabolism, choline alfoscerate for cell membrane function, carbonated water for circulation, vitamin B1 for metabolic support, and Asparagopsis taxiformis extract for fat decomposition) to achieve a satisfactory and enhanced lipolytic effect that cannot be obtained with single ingredients

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition effectively reduces subcutaneous fat, improves elasticity, and enhances circulation function without side effects like redness, swelling, or skin sagging, demonstrating superior fat decomposition and cellulite reduction.

Implementation Method 1

the hyaluronidase is included in 500 to 700 IU units

Methodology Applied
Scientific EffectHyaluronidase enzyme activity: Enzyme

Implementation Method 2

aminophylline is included in an amount of 0.05% to 0.15% (w/v)

Methodology Applied
Scientific EffectPhosphodiesterase inhibition:

Implementation Method 3

the epinephrine is included in an amount of 0.001% to 0.006% (w/v)

Methodology Applied
Scientific EffectVasoconstriction:

Implementation Method 4

the procaine is included in an amount of 0.01% to 0.03% (w/v)

Methodology Applied
Scientific EffectLocal anesthesia:

Implementation Method 5

the composition further includes 3% to 6% (v/v) of carbonated water

Methodology Applied
Scientific EffectCarbonation:

Implementation Method 6

the composition further includes 2% to 4% (w/v) of choline alfoscerate

Methodology Applied
Scientific EffectCholine metabolism:

Data Source

PatentUS20260060914A1Contour injection composition
Publication Date: 2026.03.05 HONG JONG CHEOL

AI summary

The present invention relates to a contour injection composition, and more specifically, is characterized by an injection composition comprising a solvent, aminophylline, procaine, epinephrine, and hyaluronidase, the injection composition comprising, on the basis of the entire composition, 500 to 700 IU units hyaluronidase, and 0.05 to 0.15% (w/v) aminophylline, 0.01 to 0.03% (w/v) procaine, 0.001 to 0.006% (w/v) epinephrine, and the remainder the solvent, wherein the solvent is half saline and distilled water. According to the present invention, the injection composition has excellent fat decomposition and fat destruction effects and cellulite reduction effect, as well as effect in improving a circulation function, thereby reducing subcutaneous fat in a desired area, and having the advantages not only of improving body and facial lines by improving elasticity, but also not causing side effects such as redness, itchiness, swelling, skin depression, and skin sagging.